Labatec Gets Approval To Market Futura’s Eroxon Erectile Dysfunction Gel In Saudi Arabia
Executive Summary
Futura Medical's MED3000 erectile dysfunction gel gets OTC approval in the Kingdom of Saudi Arabia, where Switzerland's Labatec Pharma has the rights to commercialize the product under the Eroxon brand.
You may also be interested in...
German Switch Committee Rejects Sildenafil And Tadalafil, Ball Now In Ministry’s Court
Germany’s Expert Committee on Prescription has gone against the wishes of the country's health ministry in rejecting Rx-to-OTC switch applications for sildenafil and tadalafil. The BMG could, in theory, ignore the SVA’s recommendation, however, such a move would be unprecedented.
‘A Phenomenon’ – Futura’s Eroxon ED Gel Gets Off To Flying Start In The UK
According to Futura's UK distributor, the recent launch of its Eroxon drug-free erectile dysfunction gel has been an outstanding success. Ceuta's Jon Connolly described the strategy behind the launch at a recent investor event.
ED Indication Reaches US OTC Market With FDA Approval Of UK Firm Futura’s Eroxon Gel
Approved through De Novo regulatory pathway used to classify novel medical devices for which there is no legally marketed predicate product, Eroxon, packaged in single-use tubes, gives Futura first entry to US market for OTC therapeutic products approved with ED indication.